<?xml version="1.0" encoding="UTF-8"?>
<ref id="B201-pharmaceuticals-14-00381">
 <label>201.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Siasos</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Tousoulis</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Tsigkou</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kokkou</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Oikonomou</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Vavuranakis</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Basdra</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Papavassiliou</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Stefanadis</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Flavonoids in atherosclerosis: An overview of their mechanisms of action</article-title>
  <source>Curr. Med. Chem.</source>
  <year>2013</year>
  <volume>20</volume>
  <fpage>2641</fpage>
  <lpage>2660</lpage>
  <pub-id pub-id-type="doi">10.2174/0929867311320210003</pub-id>
  <?supplied-pmid 23627935?>
  <pub-id pub-id-type="pmid">23627935</pub-id>
 </element-citation>
</ref>
